Mills BJ, Weiss MM, Lang CA, Liu MC, and Ziegler C (2000)
Most symptoms improve as your body adapts to treatment, typically within 23 weeks at a stable dose
Slow and steady made the whole experience manageable
The starting dose is deliberately conservative to allow for this dual adaptation
Astrup, et al.66, utilizaron la liraglutida para el tratamiento de la obesidad en 564 sujetos con ndice de masa corporal entre 30 y 40kg/m2, los cuales fueron asignados al azar a tres brazos: la liraglutida (cuatro dosis 1,2, 1,8, 2,8, 3mg), el orlistat o el placebo y los tres grupos recibieron una dieta con moderada restriccin calrica
Press Contact: Emily Passer * Based on a retrospective study of self-reported data of pounds lost for active versus passive users who were offered the Noom program when being prescribed an early stage GLP-1.